The Middle East and North Africa (MENA) region is one of the world’s highest growth markets for pharmaceuticals. The two main reasons for this are (a) the increasing health awareness in the MENA region in general, and (b) the MENA region has one of the highest rates of population growth in the world
Combine this with the reality that per-capita consumption of pharmaceuticals in MENA is much lower than developed countries, and the trend for governments to focus on curbing healthcare costs — all of this creates growth opportunities for generic pharmaceutical manufacturers.
Hayat is approved and has a market presence in 12 MENA markets, with a network of established distributors. Additionally, it is present with its own sales force in a number of strategic markets. With its market reach and excellent knowledge of regulatory requirements in the markets where it operates, Hayat is the ideal choice for any strategic partner interested in entering MENA markets.